![Novel Abuse Deterrent Formulations | American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology Novel Abuse Deterrent Formulations | American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology](https://media.americanpharmaceuticalreview.com/m/28/article/345660-fig1.jpg)
Novel Abuse Deterrent Formulations | American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology
![ABUSE DETERRENT TECHNOLOGY - New Abuse Deterrent Formulation Technology for Immediate-Release Opioids ABUSE DETERRENT TECHNOLOGY - New Abuse Deterrent Formulation Technology for Immediate-Release Opioids](https://drug-dev.com/wp-content/uploads/2013/10/F1.jpg)
ABUSE DETERRENT TECHNOLOGY - New Abuse Deterrent Formulation Technology for Immediate-Release Opioids
![Abuse deterrent immediate release film technology (ADRIFT): A novel bilayer film technology for limiting intentional drug abuse - Pharma Excipients Abuse deterrent immediate release film technology (ADRIFT): A novel bilayer film technology for limiting intentional drug abuse - Pharma Excipients](https://www.pharmaexcipients.com/wp-content/uploads/2020/10/Abuse-deterrent-immediate-release-film-technology-ADRIFT-A-novel-bilayer-film-technology-for-limiting-intentional-drug-abuse.jpg)
Abuse deterrent immediate release film technology (ADRIFT): A novel bilayer film technology for limiting intentional drug abuse - Pharma Excipients
![Innovative Abuse-Deterrent Opioid Medications | American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology Innovative Abuse-Deterrent Opioid Medications | American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology](https://media.americanpharmaceuticalreview.com/m/28/article/182873-fig2.jpg)